Propanc Secures $100M Crypto Fund for Cancer Treatment R&D
Propanc Biopharma secures $100M from Hexstone Capital for a crypto treasury, boosting cancer treatment development and investor interest through innovative financing.
Innovative Financing
The information provided on this website is provided for entertainment purposes only. We make no representations or warranties, expressed or implied, about the information. This includes its completeness, accuracy, adequacy, legality, usefulness, reliability, suitability, and availability. We also make no claims about anything else. Any reliance you place on the information is strictly your own responsibility. We accept payment from advertisers and sponsors with relevant ads. We may recommend products on our website and get paid to advertise them. You can find additional terms in the terms of use.